Literature DB >> 9918939

Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?

P Pontisso1, G Bellati, M Brunetto, L Chemello, G Colloredo, R Di Stefano, M Nicoletti, M G Rumi, M G Ruvoletto, R Soffredini, L M Valenza, G Colucci.   

Abstract

Fluctuations of hepatitis C virus (HCV)-RNA serum levels were monitored in a multicenter study in 76 chronic HCV carriers who had been followed longitudinally without receiving antiviral therapy to assess their relation with the course of liver disease activity. Forty-four patients had normal transaminases over more than 2 years, while 32 additional patients had fluctuating levels. Viral load was measured in serial serum samples prospectively collected for 10 to 12 months in 54 patients and in sera stored yearly up to 8 years in an additional 22 patients. In patients tested monthly, a lesser extent of fluctuations was detected in cases with constantly normal transaminases as compared with those with fluctuating transaminases. In the former group, the mean difference between maximum and minimum values observed in each individual patient was 0.7 Log, while in the latter group, it was 1.3 Log (P =.0004). Most of these patients experienced, on average, three peaks of viremia over 1 year. The range of variation observed upon yearly testing was between 0.2 and 2.2 Log and did not reach statistical significance between the two groups. In conclusion, a careful viral replication profile can be achieved only by monthly testing, because longer time intervals could miss viremia fluctuations. HCV-RNA levels are more stable in asymptomatic HCV carriers than in patients with biochemical activity of liver disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918939     DOI: 10.1002/hep.510290240

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.

Authors:  C L Cooper; Curtis L Cooper; Paul MacPherson; William Cameron
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

3.  Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.

Authors:  Ingmar Mederacke; Birgit Bremer; Benjamin Heidrich; Janina Kirschner; Katja Deterding; Thomas Bock; Karsten Wursthorn; Michael P Manns; Heiner Wedemeyer
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

4.  Comparison of serial Hepatitis C virus detection in samples submitted through serology for reflex confirmation versus samples directly submitted for quantitation.

Authors:  Howard B Gale; D Robert Dufour; Nazia N Qazi; Virginia L Kan
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

Review 5.  Hepatitis B virus and hepatitis C virus dual infection.

Authors:  Gaia Caccamo; Francesca Saffioti; Giovanni Raimondo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

6.  TNF-alpha inhibitors and ustekinumab for the treatment of psoriasis: therapeutic utility in the era of IL-17 and IL-23 inhibitors.

Authors:  Julie J Hong; Edward K Hadeler; Megan L Mosca; Nicholas D Brownstone; Tina Bhutani; Wilson J Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2022-01-12

7.  Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study.

Authors:  Jean-Luc Szpakowski; Lue-Yen Tucker; David M Baer; Mary Pat Pauly
Journal:  Can Liver J       Date:  2022-02-04

8.  Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis.

Authors:  John R Ticehurst; Fayez M Hamzeh; David L Thomas
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

Review 9.  Hepatitis C and pregnancy.

Authors:  Annarosa Floreani
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 10.  Natural history of hepatitis C infection: a concise review.

Authors:  J K Lim
Journal:  Yale J Biol Med       Date:  2001 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.